You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Improving Outcome in Neonatal Abstinence Syndrome

637989
Pediatrics
Jeffrey Shenberger, MD

Baystate Children's Hospital
759 Chestnut Street
Springfield, MA 01199

The purpose of this research study is to compare treatment options for infants with Neonatal Abstinence Syndrome (NAS) due to narcotic exposure in the womb and evaluate the effects of treatment on long-term neurodevelopmental outcome at 18 months of age. The goal is to compare the two most commonly used drugs and see which requires fewer days in the hospital to complete treatment.  The study will also determine if genetic variations contribute to the severity of NAS.

Dr. Jeffrey Shenberger
413-794-5370